Bullmore, E, Fletcher, P, Jones, PB.
Why psychiatry can't afford to be neurophobic. Br J Psychiatry
2009; 194: 293–5.
Dalmau, J, Tüzün, E, Wu, HY, Masjuan, J, Rossi, JE, Voloschin, A, et al.
Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol
2007; 61: 25–36.
Irani, SR, Bera, K, Waters, P, Zuliani, L, Maxwell, S, Zandi, MS, et al.
N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain
2010; 133: 1655–67.
Dalmau, J, Lancaster, E, Martinez-Hernandez, E, Rosenfeld, M, Balice-Gordon, R.
Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol
2011; 10: 63–74.
Dalmau, J, Gleichman, AJ, Hughes, EG, Rossi, JE, Peng, X, Lai, M, et al.
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol
2008; 7: 1091–8.
Vincent, A, Bien, CG, Irani, SR, Waters, P.
Autoantibodies associated with diseases of the CNS: new developments and future challenges. Lancet Neurol
2011; 10: 759–72.
Vincent, A, Buckley, C, Schott, JM, Baker, I, Dewar, BK, Detert, N, et al.
Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain. 2004; 127: 701–12.
Parthasarathi, UD, Harrower, T, Tempest, M, Hodges, JR, Walsh, C, McKenna, PJ, et al.
Psychiatric presentation of voltage-gated potassium channel antibody-associated encephalopathy. Case report. Br J Psychiatry
Zandi, MS, Irani, SR, Lang, B, Waters, P, Jones, PB, McKenna, P, et al.
Disease-relevant autoantibodies in first episode schizophrenia. J Neurol
2011; 258: 686–8.
Dementia Praecox and Paraphrenia (ed. Robertson, G). Livingstone, 1919.
Pomarol-Clotet, E, Honey, GD, Murray, GK, Corlett, PR, Absalom, AR, Lee, M, et al.
Psychological effects of ketamine in healthy volunteers. Phenomenological study. Br J Psychiatry
2006; 189: 173–9.